As of Apr 24
| -0.07 / -0.81%|
The 7 analysts offering 12-month price forecasts for Novavax Inc have a median target of 10.50, with a high estimate of 14.00 and a low estimate of 10.00. The median estimate represents a +22.38% increase from the last price of 8.58.
The current consensus among 7 polled investment analysts is to Buy stock in Novavax Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.